MTND1P8

Across TCGA pan-cancer cohorts, MTND1P8 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MTND1P8 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MTND1P8 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTND1P8 expression acts as an unfavorable survival marker, although some lineages such as READ and LAML show a favorable association.

READ, LAML, and UVM are the cancer types where MTND1P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.883	0.578	.008	29	view →
LAML	DFS	Quartile	All	0.604	0.325	.002	28	view →
UVM	DFS	Median	III,IV	0.284	0.907	.002	27	view →
CESC	DFS	Quartile	II,III,IV	0.261	0.631	.012	22	view →
ACC	OS	Tertile	IV	0.889	0.399	.019	17	view →
TGCT	DFS	Tertile	II,III,IV	0.674	1.000	.038	10	view →
COAD	DFS	Quartile	IV	0.310	0.560	.015	9	view →
PAAD	OS	Tertile	All	0.432	0.194	.016	9	view →
PCPG	OS	Tertile	All	0.791	1.000	.030	9	view →
HNSC	OS	Quartile	All	0.432	0.648	.015	9	view →
BLCA	OS	Median	III,IV	0.466	0.334	.035	7	view →
SKCM	DFS	Median	All	0.245	0.163	.009	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MTND1P8–READ (OS)

Open the READ breakdown →